KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Guardant Health (GH) Operating Expenses: 2017-2025

Historic Operating Expenses for Guardant Health (GH) over the last 8 years, with Sep 2025 value amounting to $364.2 million.

  • Guardant Health's Operating Expenses rose 17.93% to $364.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 11.39%. This contributed to the annual value of $1.2 billion for FY2024, which is 4.78% up from last year.
  • Guardant Health's Operating Expenses amounted to $364.2 million in Q3 2025, which was up 7.59% from $338.5 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Operating Expenses registered a high of $364.2 million during Q3 2025, and its lowest value of $186.5 million during Q1 2021.
  • Its 3-year average for Operating Expenses is $302.6 million, with a median of $308.8 million in 2024.
  • As far as peak fluctuations go, Guardant Health's Operating Expenses soared by 82.12% in 2021, and later declined by 7.03% in 2024.
  • Quarterly analysis of 5 years shows Guardant Health's Operating Expenses stood at $206.3 million in 2021, then surged by 32.33% to $273.0 million in 2022, then grew by 29.14% to $352.6 million in 2023, then decreased by 7.03% to $327.8 million in 2024, then increased by 17.93% to $364.2 million in 2025.
  • Its Operating Expenses was $364.2 million in Q3 2025, compared to $338.5 million in Q2 2025 and $314.5 million in Q1 2025.